3Munoz Rodriguez FJ,Font J,Cervera R,et al.Clinlcal study and followup of 100 patients with the antiphosphoslipid syudrome[J].Semin Arthritis Rheum,1999,29(3):182-190.
2MATSUURA E, KOBAYASHI K, KOIKE T, et al. Autoantibody-mediated atherosclerosis[J]. Autoimmunity Reviews, 2002,1:348.
3ERKAN D,MERRILL J T,YAZICI Y,et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin[J]. Arthritis Rheum,2001,44:1 466-1 467.
4AMENGUAL O,ATSUMI T,KHAMASHTA M A. Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium[J]. Rheumatology (Oxford),2003,42(9):1 029-1 031.
6MOLL S,ORTEL T L. Monitoring warfarin therapy in patients with lupus anticoagulants[J].Ann Intern Med,1997,127:177-185.
7LE D T,WEIBERT R T,SEVILLA B K,et al. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods[J]. Ann Intern Med,1994,120:552-558.
8BRANCH D W,KHAMASHTA M A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies[J]. Obstet Gynecol,2003,101:1 333-1 344.
9LIND S E,CALLAS P W,GOLDEN E A,et al. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy[J]. Blood Coagulation Fibrinoloysis,1997,8:48-53.
10FERRARA D E,LIU X W,ESPINOLA R G,et al. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model[J]. Arthritis Rheumatism,2003,40(11):3 272-3 279.
